Overactive Bladder is a Distress Symptom in Heart Failure
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The prevalence of Heart failure (HF) is expected to increase worldwide with the aging population trend. The numerous symptoms of and repeated hospitalizations for HF negatively affect the patient’s quality of life and increase the patient’s economic burden. Up to 50% of patients with HF suffer from urinary incontinence (UI) and an overactive bladder (OAB). However, there are limited data about the relationship between UI, OAB, and HF. The association between HF and urinary symptoms may be directly attributable to worsening HF pathophysiology. A comprehensive literature review was conducted for all publications between January 2000 and November 2017 using the PubMed, Embase, and Cochrane databases. HF represents a major and growing public health problem, with an increased risk of UI and an OAB as comorbidities. Possible effects of HF on urinary problems may be mediated by the prescription of medications for symptomatic relief. Although diuretics are typically used to relieve congestion, and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers improve survival, these classes of drugs have been suggested to worsen urinary symptoms in the presence of HF. Further research is required to understand the impact of UI and an OAB on the HF illness trajectory.
Abstract
The prevalence of Heart failure (HF) is expected to increase worldwide with the aging population trend. The numerous symptoms of and repeated hospitalizations for HF negatively affect the patient’s quality of life and increase the patient’s economic burden. Up to 50% of patients with HF suffer from urinary incontinence (UI) and an overactive bladder (OAB). However, there are limited data about the relationship between UI, OAB, and HF. The association between HF and urinary symptoms may be directly attributable to worsening HF pathophysiology. A comprehensive literature review was conducted for all publications between January 2000 and November 2017 using the PubMed, Embase, and Cochrane databases. HF represents a major and growing public health problem, with an increased risk of UI and an OAB as comorbidities. Possible effects of HF on urinary problems may be mediated by the prescription of medications for symptomatic relief. Although diuretics are typically used to relieve congestion, and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers improve survival, these classes of drugs have been suggested to worsen urinary symptoms in the presence of HF. Further research is required to understand the impact of UI and an OAB on the HF illness trajectory.
참고문헌 (46)
- Tan LB, "So many definitions of heart failure: are they all universally valid? A critical appraisal", Expert Rev Cardiovasc Ther, 8, pp.217~228 (2010)[DOI]
- Palmer MH, "Relationship between heart failure and overactive bladder", Curr Bladder Dysfunct Rep, 5, pp.18~22 (2010)[DOI]
- Lee H, "Prevalence and socioeconomic burden of heart failure in an aging society of South Korea", BMC Cardiovasc Disord, 16, pp.215~ (2016)[DOI]
- The annual statistical report of the cause of death 2014, "Korean National Statistical Office", Statistics Korea, ~
- Retrum JH, "Patient-identified factors related to heart failure readmissions", Circ Cardiovasc Qual Outcomes, 6, pp.171~177 (2013)[DOI]
- Bartoli S, "Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review", Urology, 75, pp.491~500 (2010)[DOI]
- Sexton CC, "Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study", J Am Geriatr Soc, 59, pp.1465~1470 (2011)[DOI]
- Andersson KE, "Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder", BJU Int, 106, pp.268~274 (2010)
- Bouwman II, "Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and metaanalysis", World J Urol, 33, pp.1911~1920 (2015)[DOI]
- Palmer MH, "Urinary incontinence and overactive bladder in patients with heart failure", J Urol, 182, pp.196~202 (2009)[DOI]
- Altunoluk B, "Relationship between the use of diuretics and overactive bladder in patients with heart failure", J Clin Anal Med, 5, pp.107~109 (2014)
- Tannenbaum C, "Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence", Drugs Aging, 31, pp.93~101 (2014)[DOI]
- Hwang R, "Frequency of urinary incontinence in people with chronic heart failure", Heart Lung, 42, pp.26~31 (2013)[DOI]
- Lindeman K, "Help-seeking for incontinence by individuals with heart failure", J Am Geriatr Soc, 60, pp.1994~1995 (2012)[DOI]
- Lee PG, "The co-occurrence of chronic diseases and geriatric syndromes: the health and retirement study", J Am Geriatr Soc, 57, pp.511~516 (2009)[DOI]
- Bierman AS, "Coexisting illness and heart disease among elderly Medicare managed care enrollees", Health Care Financ Rev, 25, pp.105~117 (2004)
- Chiu AF, "High classification of chronic heart failure increases risk of overactive bladder syndrome and lower urinary tract symptoms", Urology, 79, pp.260~265 (2012)[DOI]
- Rosa GM, "Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder", Expert Opini Drug Saf, 17, pp.487~497 (2018)[DOI]
- DuBeau CE, "Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence", Neurourol Urodyn, 29, pp.165~178 (2010)[DOI]
- Kim HN, "Biomarkers in the management of heart failure", Curr Treat Options Cardiovasc Med, 12, pp.519~531 (2010)[DOI]
- Yoshimura K, "B-type natriuretic peptide as an independent correlate of nocturnal voiding in Japanese women", Neurourol Urodyn, 31, pp.1266~1271 (2012)[DOI]
- Raphael C, "Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure", Heart, 93, pp.476~482 (2007)[DOI]
- Lesman-Leegte I, "Depressive symptoms are prominent among elderly hospitalised heart failure patients", Eur J Heart Fail, 8, pp.634~640 (2006)[DOI]
- Grippo AJ, "Mechanisms underlying altered mood and cardiovascular dysfunction: the value of neurobiological and behavioral research with animal models", Neurosci Biobehav Rev, 33, pp.171~180 (2009)[DOI]
- Zorn BH, "Urinary incontinence and depression", J Urol, 162, pp.82~84 (1999)[DOI]
- Choi JB, "Analysis of heart rate variability in female patients with overactive bladder", Urology, 65, pp.1109~1112 (2005)[DOI]
- Yu CJ, "Medical disease affecting lower urinary tract symptoms", Urol Sci, 24, pp.41~45 (2013)[DOI]
- Fitzgerald MP, "Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses", Eur Urol, 52, pp.407~415 (2007)[DOI]
- van Gerwen M, "Comorbidities associated with urinary incontinence: a case-control study from the Second Dutch National Survey of General Practice", J Am Board Fam Med, 20, pp.608~610 (2007)[DOI]
- Coyne KS, "Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS", BJU Int, 103(Suppl 3), pp.24~32 (2009)
- Faris R, "Diuretics for heart failure", Cochrane Database Syst Rev, (1) (2006)
- Yip GW, "The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction", Heart, 94, pp.573~580 (2008)[DOI]
- Ekundayo OJ, "Association of diuretic use and overactive bladder syndrome in older adults: a propensity score analysis", Arch Gerontol Geriatr, 49, pp.64~68 (2009)[DOI]
- Kazi D, "Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure", Cardiol Clin, 26, pp.1~14 (2008)[DOI]
- Hall SA, "Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey", BJU Int, 109, pp.1676~1684 (2012)[DOI]
- Segall L, "Heart failure in patients with chronic kidney disease: a systematic integrative review", Biomed Res Int, 2014, pp.937398~ (2014)
- Foody JM, "beta-Blocker therapy in heart failure: scientific review", JAMA, 287, pp.883~889 (2002)[DOI]
- Ruby CM, "Medication use and control of urination among community-dwelling older adults", J Aging Health, 17, pp.661~674 (2005)[DOI]
- Lewandowski J, "Beneficial influence of carvedilol on urologic indices in patients with hypertension and benign prostatic hyperplasia: results of a randomized, crossover study", Urology, 82, pp.660~665 (2013)[DOI]
- Klatsky AL, "Alcohol and cardiovascular diseases: where do we stand today?", J Intern Med, 278, pp.238~250 (2015)[DOI]
- Partsch H, "Compression therapy: clinical and experimental evidence", Ann Vasc Dis, 5, pp.416~422 (2012)[DOI]
- van der Wal MH, "Compliance with non-pharmacological recommendations and outcome in heart failure patients", Eur Heart J, 31, pp.1486~1493 (2010)[DOI]
- Andersson KE, "Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction", Br J Clin Pharmacol, 72, pp.186~196 (2011)[DOI]
- Rosa GM, "Cardiovascular effects of antimuscarinic agents in overactive bladder", Expert Opin Drug Saf, 12, pp.815~827 (2013)[DOI]
- Rosa GM, "Cardiovascular safety of <TEX>${\beta}3$<", TEX>-adrenoceptor agonists for the treatment of patients with overactive bladder syndrome, 2016, pp.69, 311~323
- Thiagamoorthy G, "The efficacy and tolerability of mirabegron, a <TEX>${\beta}3$<", TEX> adrenoceptor agonist, in patients with symptoms of overactive bladder, 2016, pp.8, 38~46